Quarterly ResultMay 12, 2026, 04:23 PM
Tenon Medical Q1 Revenue $1.4M, +90%; Gross Profit $0.9M, +193%
AI Summary
Tenon Medical, Inc. reported strong financial results for the first quarter ended March 31, 2026, with revenue increasing by 90% to $1.4 million and gross profit surging by 193% to $0.9 million. The company also significantly improved its gross margin to 68.5% and reduced its net loss year-over-year. Additionally, Tenon Medical closed a $4.3 million private placement to support commercial expansion and product development, while also strengthening its intellectual property portfolio and expanding its training and sales presence.
Key Highlights
- Q1 2026 Revenue was $1.4 million, an increase of approximately 90% compared to prior year.
- Q1 2026 Gross Profit was $0.9 million, an increase of approximately 193% compared to prior year.
- Gross margin expanded approximately 24 percentage points year-over-year to 68.5% in Q1 2026.
- Net loss for Q1 2026 was $3.5 million, or $0.31 per share, an improvement from $3.6 million, or $1.01 per share, in Q1 2025.
- Closed a $4.3 million senior convertible note private placement to fund commercial expansion and product development.
- Cash and cash equivalents totaled $4.6 million as of March 31, 2026, up from $3.8 million at December 31, 2025.
- Strengthened intellectual property portfolio with multiple Notices of Allowance, adding to 29 issued U.S. patents and 9 international patents.
- Opened a new Center of Excellence Training Center in Tampa, FL, and expanded sales leadership in the Eastern Region.